IDO1 and congenital rubella syndrome: In addition, our functional validation study also showed that manipulation of tryptophan metabolism by IDO1 inhibitor led to marked decline in proinflammatory cytokines, indicating its therapeutic potential in controlling CRS in the SARS-CoV-2 infection.